PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9528046

[Spontaneous intracranial hematomas. A surgical solution?].

R Hodelín-Tablada
View original source ↗Export metadata ↓

Abstract

INTRODUCTION: Spontaneous intracranial haematomas pose a fundamental question for the neurosurgeon: Should he operate or not? The main objective of this paper is to consider recent ideas on this subject. A detailed review of the literature was carried out and then discussed. DEVELOPMENT: This study has been structured as supratentorial haematomas, infratentorial haematomas (cerebellum and brainstem) and multiple cerebral haematomas. We emphasize the importance of CT scanning to surgical decision-making. In supratentorial haematomas, surgery is considered to be indicated in patients with blood clots of between 2 and 3 cm in diameter, and whose neurological state is starting to deteriorate. Patients with cerebellar haematomas are classified into four groups, depending on the level of consciousness and the diameter of the clot. In these patients surgery is indicated basically in patients, both alert and somnolent, with haematomas greater than 3 cm. Medical treatment is recommended in patients with multiple haematomas and haematomas localized to the brain-stem. It is suggested that the best time to evacuate the haematoma is between 2 and 6 hours after onset. CONCLUSIONS: We consider that with the development of modern neuro-imaging techniques, intensive care units, neurological monitorization, developments in neurosurgical techniques with the use of magnification, the ultrasonic aspirator and stereotactic techniques, there will be more and more patients with spontaneous intracranial haematomas who can be successfully treated surgically in the next few years.

Explore related subjects

Cerebral HemorrhageDiagnosis, DifferentialHematomaHumansSeverity of Illness IndexStereotaxic TechniquesTime FactorsEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Hodelín-Tablada. 1997. [Spontaneous intracranial hematomas. A surgical solution?].. https://pubmed.ncbi.nlm.nih.gov/9528046/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

Genetically predicted on-statin LDL response is associated with higher intracerebral haemorrhage risk.

Statins lower low-density lipoprotein cholesterol and are widely used for the prevention of atherosclerotic cardiovascular disease. Whether statin-induced low-density lipoprotein reduction increases risk of intracerebral haemorrhage has been debated for almost two decades. Here, we explored whether genetically predicted on-statin low-density lipoprotein response is associated with intracerebral haemorrhage risk using Mendelian randomization. Using genomic data from randomized trials, we derived a polygenic score from 35 single nucleotide polymorphisms of on-statin low-density lipoprotein response and tested it in the population-based UK Biobank. We extracted statin drug and dose information from primary care data on a subset of 225 195 UK Biobank participants covering a period of 29 years. We validated the effects of the genetic score on longitudinal low-density lipoprotein measurements with generalized mixed models and explored associations with incident intracerebral haemorrhage using Cox regression analysis. Statins were prescribed at least once to 75 973 (31%) of the study participants (mean 57 years, 55% females). Among statin users, mean low-density lipoprotein decreased by 3.45 mg/dl per year [95% confidence interval (CI): (-3.47, -3.42)] over follow-up. A higher genetic score of statin response [1 standard deviation (SD) increment] was associated with significant additional reductions in low-density lipoprotein levels [-0.05 mg/dl per year, (-0.07, -0.02)], showed concordant lipidomic effects on other lipid traits as statin use and was associated with a lower risk for incident myocardial infarction [hazard ratio per SD increment 0.98 95% CI (0.96, 0.99)] and peripheral artery disease [hazard ratio per SD increment 0.93 95% CI (0.87, 0.99)]. Over a 11-year follow-up period, a higher genetically predicted statin response among statin users was associated with higher intracerebral haemorrhage risk in a model adjusting for statin dose [hazard ratio per SD increment 1.16, 95% CI (1.05, 1.28)]. On the contrary, there was no association with intracerebral haemorrhage risk among statin non-users (P = 0.89). These results provide further support for the hypothesis that statin-induced low-density lipoprotein reduction may be causally associated with intracerebral haemorrhage risk. While the net benefit of statins for preventing vascular disease is well-established, these results provide insights about the personalized response to statin intake and the role of pharmacological low-density lipoprotein lowering in the pathogenesis of intracerebral haemorrhage.

Cerebral Hemorrhage↗
PubMed2006

Visual development in infants with prenatal post-haemorrhagic ventricular dilatation.

OBJECTIVE: The aim of this study was to assess visual function in 13 infants with evidence of prenatal post haemorrhagic ventricular dilatation. DESIGN: Infants were assessed at 5, 12 and 24 months using a battery of tests specifically designed to assess various aspects of visual function in infancy. Visual findings were correlated with several variables, including extent of the lesion and presence of epilepsy. RESULTS AND CONCLUSIONS: Abnormalities of visual function were frequent (over 60%) in our cohort at age 2 years, ranging from isolated abnormal ocular movements to severe abnormalities of all the aspects of visual function assessed. The most severe and persistent abnormalities of visual function were found in infants with grade IV intraventricular haemorrhage and shunted hydrocephalus who also had epilepsy in the first year.

Cerebral Hemorrhage↗